Provectus Biopharmaceuticals Price on February 13, 2024

PVCTDelisted Stock  USD 0.11  0.00  0.00%   
If you're considering investing in Provectus OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Provectus Biopharmaceutica stands at 0.11, as last reported on the 22nd of December, with the highest price reaching 0.11 and the lowest price hitting 0.11 during the day. We have found nineteen technical indicators for Provectus Biopharmaceutica, which you can use to evaluate the volatility of the company. Please check Provectus Biopharmaceutica's Risk Adjusted Performance of (0.03), coefficient of variation of (1,840), and Variance of 32.57 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Provectus OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PVCT
Based on monthly moving average Provectus Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Provectus Biopharmaceutica by adding Provectus Biopharmaceutica to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Provectus Biopharmaceutica OTC Stock history

Provectus Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Provectus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Provectus Biopharmaceutica will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Provectus Biopharmaceutica stock prices may prove useful in developing a viable investing in Provectus Biopharmaceutica
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. Provectus Biopharmaceuticals, Inc. was incorporated in 2002 and is based in Knoxville, Tennessee. Provectus Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.

Provectus Biopharmaceutica OTC Stock Technical Analysis

Provectus Biopharmaceutica technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Provectus Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Provectus Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Provectus Biopharmaceutica Period Price Range

Low
December 22, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Provectus Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Provectus Biopharmaceutica December 22, 2024 Market Strength

Market strength indicators help investors to evaluate how Provectus Biopharmaceutica otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Provectus Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Provectus Biopharmaceutica otc stock market strength indicators, traders can identify Provectus Biopharmaceuticals entry and exit signals to maximize returns

Provectus Biopharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Provectus Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of Provectus OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Provectus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Consideration for investing in Provectus OTC Stock

If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Transaction History
View history of all your transactions and understand their impact on performance